IndraLab

Statements


| 1

sparser
"A series of pre-clinical studies have shown that 177 Lu-HH1 successfully binds to both lymphoma cell lines and biopsies from NHL patients, indicating that targeting of the CD37 antigen with HH1 is clinically relevant [ xref ]."